The eligibility of long term hemodialysis catheters under the Nairobi Protocol from an undisclosed country
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated August 6, 2025, you requested a tariff classification ruling on behalf of your client Teleflex LLC. The items under consideration are hemodialysis catheters, Arrow Edge Hemodialysis Catheter (“Arrow Edge”), as well as Arrow-Clark Vector Flow Antegrade Chronic Hemodialysis Catheter (“Arrow-Clark Antegrade”) and the Arrow-Clark Vector Flow Retrograde Hemodialysis Catheter (“Arrow-Clark Retrograde”) (collectively “Arrow-Clarks”).
The catheters are two-lumen polyurethane central venous catheters designed for long term vascular access for hemodialysis and apheresis. All three catheters perform the same function and achieve the same medical outcome but use different placement techniques and have different tip designs. The Arrow Edge is designed to provide optimal performance by delivering high flow rates, up to 400 cubic centimeters (“cc”) per minute, at low pressures.
The crescent-shape of the catheter’s distal V- tip is designed to promote blood flow even if the tip is resting against the vessel wall. The Arrow-Clarks are symmetrical-tip, tunneled hemodialysis catheters designed to provide sustained high flows, reduce loss of lock solution, and reduce the risk of thrombus accumulation due to platelet activation resulting from shear stress.
Available in both retrograde and antegrade insertion platforms, Arrow-Clarks are designed with an innovative tip that allows placement flexibility with minimal impact on recirculation rates. The three catheters are inserted percutaneously and are preferentially placed into the internal jugular vein. They primarily are intended for individuals with end stage renal disease (“ESRD”).
You state the catheters, are intended for the long-term and repeated removal of waste, toxins, and excess fluids from the blood during hemodialysis treatment, have no alternative application, are sold only to medical facilities for use by licensed medical professionals, and are distributed through medical device channels for ESRD treatment.
In your submission you requested consideration of a classification under 9817.00.96, Harmonized Schedule of the United States, (HTSUS), which applies to articles and parts and accessories of articles specifically designed or adapted for the use or benefit of the permanently or chronically physically or mentally handicapped.
Subheading 9817.00.96, HTSUS, covers: “[a]rticles specially designed or adapted for the use or benefit of the blind or other physically or mentally handicapped persons; parts and accessories (except parts and accessories of braces and artificial limb prosthetics) that are specially designed or adapted for use in the foregoing articles: [o]ther.” The term “blind or other physically or mentally handicapped persons” includes “any person suffering from a permanent or chronic physical or mental impairment which substantially limits one or more major life activities, such as caring for one’s self, performing manual tasks, walking, seeing, hearing, speaking, breathing, learning, or working.” U.S. Note 4(a), Subchapter XVII, Chapter 98, HTSUS.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N352076).